Natasha Tiffany, MD, is a physician, educator, and research scientist currently working in Oregon. A Partner and Physician in a private practice located in the state's capital city of Salem, Dr. Tiffany teaches at her alma mater, Oregon Health & Science University, where she is an Affiliate Assistant Professor in the Hematology and Medical Oncology Division.
Highly respected as both an educator and a physician, Dr. Natasha Tiffany served on the Curriculum Committee at Massachusetts General Hospital for the Internal Medicine Residency Program, and was Associate Editor of the Hospital's Ambulatory Care Syllabus. For two years, she was part of the Steering Committee at OHSU for developing the Principles of Clinical Medicine, and was part of OHSU's Medical Oncology Fellowship Committee.
Natasha Tiffany, MD, has worked on several medical research projects. While an undergraduate, she mentored with Steven Gancher, MD, on a project exploring the buildup of tolerance to the drug apomorphine in a rat model of Parkinson's disease. During her summer breaks and after graduation, Dr. Tiffany worked with OHSU Professor Emeritus William Woodward, Ph.D, on a study of the growth of fibroblasts in rats that experienced injury to their central nervous systems through mechanical means or lack of blood flow. She was awarded the Oberlin College Neuroscience and Biopsychology Award in 1992.
After completing her medical degree, Dr. Natasha Tiffany conducted a two-year research project under the direction of Tomasz Beer, MD, at OHSU. Focusing on the potential toxicity of the drugs Gleevec and Zometa for the treatment of androgen-independent prostate cancer, Dr. Tiffany explored the potential efficacy of the drugs, which have been used in treating chronic myelogenous leukemia and gastrointestinal stromal tumors.
Continuing her interest in medical research, Dr. Natasha Tiffany sits on the Board of Directors of Willamette Clinical Research Inc. in Salem, Oregon. Additionally, she currently serves as Vice-Chair of the Breast Cancer Committee for the Salem Cancer Institute, which she has supported since 2008.